Another potential avenue for treating resistant hypertension

Kim Carollo | | Cardiovascular Business | Vascular & Endovascular

Patients with obstructive sleep apnea (OSA) and resistant hypertension who used continuous positive airway pressure (CPAP) had lower blood pressure over a 12-week period, according to a study published online Dec. 11 in JAMA.

Prior research has suggested that CPAP may reduce blood pressure, but whether the effect is observed in people with resistant hypertension is unclear.

“The objective of our study was to conduct a randomized, multicenter clinical trial to assess the effect of CPAP treatment on blood pressure values and nocturnal blood pressure patterns of patients with resistant hypertension and OSA,” explained the authors, led by Miguel-Angel Martinez-Garcia, MD, PhD, of University Hospital La Fe in Valencia, Spain.

They randomly assigned 194 patients with both resistant hypertension and OSA to receive either CPAP or no CPAP (control group) over a 12-week period between June 2009 and October 2011. Resistant hypertension was defined as an average systolic blood pressure (SBP) of 130 mm Hg or higher, a diastolic blood pressure (DBP) of 80 mm Hg or higher or both despite the use of at least three medications to control blood pressure. The primary outcome was the change in the ambulatory mean blood pressure in a 24-hour period. The investigators also assessed day and night SBP as well as changes in blood pressure patterns during the night.

At the start of the study, 25.8 percent of patients experienced at least a 10 percent decrease in average nocturnal blood pressure compared with diurnal blood pressure (the “dipper pattern”). In the group using CPAP for at least four hours per day, that percentage jumped to 72.4 percent.

Compared with controls, the decrease in 24-hour average blood pressure in the CPAP group was 3.1 mm Hg greater and the decrease in the 24-hour DBP was 3.2 mm Hg greater. The dipper pattern was greater in the CPAP group as well (35.9 percent vs. 21.6 percent).

While these findings suggested a short-term benefit of CPAP in this patient population, the authors noted that there should be additional research to determine whether any long-term effects exist.

 

Kim Carollo,

Contributor

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."